Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
New MSL: The 4 “Ts” to Prepare for and Overcome
Summary
In this episode, Lauren Gardner shares her journey into the Medical Science Liaison (MSL) role, offering insights into effective time management and territory planning. She discusses the importance of engaging with Key Opinion Leaders (KOLs) and the power of storytelling in the MSL field. Lauren provides valuable advice for new MSLs, addressing future challenges and emphasizing the role of adaptability and intentionality. The conversation highlights networking strategies and the significance of finding joy in the MSL career. The episode concludes with Lauren's final thoughts on maintaining a fulfilling career and a call to action for listeners.
Today’s guest is Lauren Gardner, Senior Medical Ambassador (MSL) at Tarsus Pharmaceuticals and we discuss her experience as a new MSL and the 4 T’s (challenges) to prepare for and overcome
Lauren discusses….
👉 What it took to help land her first MSL role
👉 The challenges she is faces as a new MSL
👉 Calling on and engaging with KOLs and what it has been like so far
👉 Tools and resources that are helpful to her
👉 Tips and advice for other new MSLs
👉 Tips and advice for aspiring MSLs
Medical Science Liaison, Key Opinion Leaders, MSL career tips, networking strategies, storytelling in MSL
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD